UK Diagnostic Biomarker Market Size, Share, Trends & Forecast 2019-2025

1. Orion Market Research UK Diagnostic Biomarker Market Size, Segmentation, Share, Forecast, Analysis, Industry Report to 2025 Request a Free Sample of our Report onUK Diagnostic Biomarker Market @ https://www.omrglobal.com/request-sample/uk-diagnostic-biomarker-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

2. The UK diagnostic biomarker market is estimated to grow significantly at a CAGR of more than 12% during the forecast period. The major factor that is driving the market includes a high prevalence of cancer and chronic diseases in the region. Furthermore, the nation has the highest number of CVD, Congenital heart disease (CHD), stroke, heart failure, atrial fibrillation, and other heart-related diseases. According to the British Heart Foundation in 2017, more than one-fourth of the fatalities in UK are due to CVD, which is responsible for around 1.6 million fatalities each year. The rise in such diseases increases the demand for efficient diagnostic techniques and hence drives the growth of the market in the region. A full report of UK Diagnostic Biomarker Market is available at https://www.omrglobal.com/industry- reports/uk-diagnostic-biomarker-market The UK diagnostic biomarker market is segmented on the basis of diagnostic technique and application. On the basis of the diagnostic technique, the market is segmented into ELISA, colorimetric assay, liquid chromatography-mass spectrometry, particle-enhanced turbidimetric immunoassay and other. Further, on the basis of application, the market is segmented into oncology, cardiology, neurology, nephrology, and others. There is a huge scope for the market in the oncology segment due to the increasing prevalence of cancer. A large number of researches are going on finding a diagnostic biomarker for various types of cancer so that early detection can be done. The major players in the UK diagnostic biomarker market include Abbott Laboratories, Inc., Thermo Fisher Scientific, inc., F. Hoffmann-La Roche Ltd., Evotec AG, Becton Dickinson and Co., Qiagen NV, Novartis AG, and others. These companies are launching innovative products in the market, in order to meet the increasing demand for an effective diagnostic biomarker for cancer and cardiovascular diseases. Furthermore, the market players are adopting various strategies, in order to sustain in the competitive market, which includes partnership and collaboration, and investments. UK Diagnostic Biomarker Market Segmentation By Diagnostic Technique • ELISA • Colorimetric Assay • Liquid Chromatography-Mass Spectrometry • Particle-Enhanced Turbidimetric Immunoassay • Others

3. By Application • Oncology • Cardiology • Neurology • Nephrology • Others Company Profiles • Abbott Laboratories Inc. • Abcodia Ltd. • Agilent Technologies, Inc. • Avacta Group Plc • Bayer AG • Becton, Dickson and Co. • BioMérieux S.A. • Bio-Rad Laboratories, Inc. • Eurofins Scientific SE • Evotec AG For More Customized Data, Request for Report Customization@ https://www.omrglobal.com/report- customization/uk-diagnostic-biomarker-market About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404